Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study
Zou, L; Li, XC; Wu, XS; Cui, JJ; Cui, XY; Song, XL; Ren, T; Han, XS; Zhu, YD; Li, HF; Wu, WG; Wang, X; Gong, W; Wang, LW; Li, ML; Lau, WY; Liu, YB
Li, ML (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai 200092, Peoples R China.; Liu, YB (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Biliary Pancreat Surg, Shanghai 200127, Peoples R China.; Wang, LW (corresponding author), Renji Hosp, Shanghai Canc Inst, Sch Med, Dept Med Oncol, Shanghai 200127, Peoples R China.; Lau, WY (corresponding author), Chinese Univ Hong Kong, Fac Med, Shatin, Hong Kong, Peoples R China.
BMC CANCER, 2021; 21 (1):
